Response Biomedical Corporation Receives Notice of Allowance from United States Patent and Trademark Office (T-Net British Columbia)

Response Biomedical Corporation Receives Notice of Allowance from United States Patent and Trademark Office (T-Net British Columbia)
Vancouver, BC, February 1, 2007–(T-Net)–Response Biomedical (TSX-V: RBM, OTCBB: RPBIF) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for the patent, entitled “Sensitive Immunochromatographic Assay”.